Literature DB >> 11517159

Stage-dependent regulation of ovarian pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH in cultured rat granulosa cells.

J Y Park1, J H Park, H J Park, J Y Lee, Y I Lee, K Lee, S Y Chun.   

Abstract

The present study was designed to test whether GnRH regulates pituitary adenylate cyclase-activating polypeptide mRNA levels in a stage-dependent manner during follicle development in the rat ovary. The granulosa cells of preovulatory and immature follicles obtained from PMSG- and estrogen-treated rats, respectively, were cultured in serum-free conditions in the presence of various hormones. GnRH receptor mRNA expression was detected in both preovulatory and immature granulosa cells and was down-regulated by gonadotropins. Treatment of preovulatory granulosa cells with GnRH agonist stimulated pituitary adenylate cyclase-activating polypeptide mRNA levels in a dose-dependent manner. In situ hybridization analysis of cultured preovulatory follicles revealed that GnRH-induced pituitary adenylate cyclase- activating polypeptide signals were detected in granulosa cells, but not thecal cells. In immature granulosa cells, cotreatment with GnRH agonist suppressed FSH-stimulated pituitary adenylate cyclase-activating polypeptide mRNA levels in a dose-dependent manner, whereas treatment with GnRH alone had no effect. Furthermore, treatment with GnRH antagonist inhibited LH-induced pituitary adenylate cyclase-activating polypeptide gene expression in preovulatory granulosa cells, whereas it stimulated FSH-induced pituitary adenylate cyclase-activating polypeptide gene expression in immature granulosa cells. Interestingly, GnRH-stimulated pituitary adenylate cyclase-activating polypeptide mRNA levels in preovulatory granulosa cells was inhibited by arachidonyltri fluoromethyl ketone, an inhibitor of phospholipase A(2), but not by an inhibitor of protein kinase A or C. Lastly, treatment of preovulatory follicles with pituitary adenylate cyclase-activating polypeptide antagonist suppressed GnRH-stimulated progesterone production during 6--9 h of culture. Taken together, these results demonstrate the stage-dependent regulation of pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH, the stimulatory and inhibitory effect in granulosa cells of preovulatory and immature follicles, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517159     DOI: 10.1210/endo.142.9.8384

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  GATA augments GNRH-mediated increases in Adcyap1 gene expression in pituitary gonadotrope cells.

Authors:  Robin L Thomas; Natalie M Crawford; Constance M Grafer; Weiming Zheng; Lisa M Halvorson
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

2.  Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment.

Authors:  M Koppan; A Varnagy; D Reglodi; R Brubel; J Nemeth; A Tamas; L Mark; J Bodis
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

3.  GnRH stimulates expression of PACAP in the pituitary gonadotropes via both the PKA and PKC signaling systems.

Authors:  Constance M Grafer; Robin Thomas; Litsa Lambrakos; Ignacio Montoya; Sheryl White; Lisa M Halvorson
Journal:  Mol Endocrinol       Date:  2009-04-02

4.  Hormonal regulation of GnRH and LHbeta mRNA expression in cultured rat granulosa cells.

Authors:  Naomi Litichever; Eran Gershon; Nava Dekel; Yitzhak Koch
Journal:  J Mol Neurosci       Date:  2009-02-28       Impact factor: 3.444

Review 5.  Female reproductive functions of the neuropeptide PACAP.

Authors:  Miklos Koppan; Zsuzsanna Nagy; Inez Bosnyak; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

6.  Role of PACAP in Female Fertility and Reproduction at Gonadal Level - Recent Advances.

Authors:  Dora Reglodi; Andrea Tamas; Miklos Koppan; Donat Szogyi; Laura Welke
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-11       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.